BEGIN:VCALENDAR
PRODID:-//planitpurple.northwestern.edu//iCalendar Event//EN
VERSION:2.0
CALSCALE:GREGORIAN
METHOD:PUBLISH
CLASS:PUBLIC
BEGIN:VTIMEZONE
TZID:America/Chicago
TZURL:http://tzurl.org/zoneinfo-outlook/America/Chicago
X-LIC-LOCATION:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:19700308T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:19701101T020000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
SEQUENCE:0
DTSTART;TZID=America/Chicago:20260305T100000
DTEND;TZID=America/Chicago:20260305T110000
DTSTAMP:20260212T000000
SUMMARY:BMG Seminar: Viktor Adalsteinsson\, PhD
UID:639025@northwestern.edu
TZID:America/Chicago
DESCRIPTION:The Department of Biochemistry & Molecular Genetics presents:  Viktor Adalsteinsson\, PhD Director\, Gerstner Center for Cancer Diagnostics  Broad Institute of MIT and Harvard   Presentation: "New technologies for circulating tumor DNA detection"  Liquid biopsies could enable more precise cancer care\, yet higher sensitivity is needed to detect the earliest stages of cancer and minimal residual disease (MRD)\, and to enable tumor molecular profiling from circulating tumor DNA (ctDNA) for all patients. In this talk\, I will describe new technologies to improve liquid biopsy testing such as MAESTRO\, an ultrasensitive test for MRD\, and the first injectable priming agents for liquid biopsies that recover >10-fold more ctDNA from the body.  Host: Dr. Yaping Liu\, PhD  Refreshments will be served.      
LOCATION:Robert H Lurie Medical Research Center\, Baldwin Auditorium\, 303 E. Superior\, Chicago\, IL 60611
TRANSP:OPAQUE
URL:
CREATED:20260212T000000
STATUS:CONFIRMED
LAST-MODIFIED:20260224T131145
PRIORITY:0
BEGIN:VALARM
TRIGGER:-PT10M
ACTION:DISPLAY
DESCRIPTION:Reminder
END:VALARM
END:VEVENT
END:VCALENDAR